| Trial ID: | L5016 |
| Source ID: | NCT01487421
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin aspart|DRUG: insulin detemir
|
| Outcome Measures: |
Primary: HbA1c (glycosylated haemoglobin) | Secondary: Fasting blood glucose (FBG)|2-hours postprandial blood glucose|Hypoglycemia|Weight development|Adverse Drug Reactions (ADRs) including Serious Adverse Drug Reactions (SADRs)
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
2134
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2003-07
|
| Completion Date: |
2006-10
|
| Results First Posted: |
|
| Last Update Posted: |
2014-06-24
|
| Locations: |
Mainz, 55127, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01487421
|
